Clinical Trial Update: Efficacy and Safety of Chondron (Autologus Chondrocyte) in Patients With Cartilage Defects in Their Ankle [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Chondron for ankle articular cartilage defects and degenerative ankle osteoarthritis; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defect of the Ankle
• Osteoarthritis of the Ankle

Drugs mentioned

• Chondron (Autologous chondrocyte implantation)

Snippet

Sponsor: Cellontech Co., Ltd. | Conditions: Defect of Articular Cartilage, Degenerative Joint Disease of Ankle and/or Foot | Phase 3 | Status: TERMINATED